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Summary Maxillary sinus carcinomas comprise 80% of tumors of the paranasal
sinuses. The majority of maxillary sinus carcinomas are usually locally advanced
at diagnosis because their symptoms are nonspecific. Treatment of these tumors
has included chemotherapy, radiotherapy and surgery or combination of those ther-
apies. We report here application of microwave coagulation therapy for tumor vol-
ume reduction in a patient with advanced clear cell adenocarcinoma of the
maxillary sinus. We selected this treatment because the patient also had inoperable
hepatocellular carcinoma and lung metastasis. Consequently, better local control
and quality of life were obtained with microwave coagulation therapy.c 2005 Elsevier Ltd. All rights reserved.
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MIntroduction
Microwave coagulation therapy (MCT) was devel-
oped in order to coagulate a hepatocellular carci-
noma tissue. The microwave-induced tissue741-9409/$ - see front matter c 2005 Elsevier Ltd. All rights rese
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atsuura).coagulation mechanism is a part of the electromag-
netic spectrum, and at a frequency of 2,450 MHz
per second, it penetrates several centimeters into
biological tissues. This energy is absorbed and con-
verted into heat within the tissue. Therefore, the
greatest advantage of this therapy is predominant
tissue coagulation ability.1–3 Thus, even in a maxil-
lofacial region, MCT may be applied to easy bleed-
ing tumors, such as hemangiomas and other benign
tumors.4,5 However, it has not yet been reportedrved.
62 H. Matsuura et al.that MCT is applicable to inoperable multiple can-
cers in this region.
The present case report deals with our experi-
ence using a microwave coagulator for local con-
trol of maxillary sinus clear cell adenocarcinoma
in a patient with hepatocellular carcinoma and lung
metastasis.Figure 2 (A) Clinical features of intraoral mass lesion
at first visit. (B) The tumor was reduced after second
MCT.Microwave coagulation strategy
A Microtaze (OT-110 M; Azwell Inc., Osaka, Ja-
pan; Fig. 1) was used as a microwave coagulator.
Microwave irradiation was performed for coagula-
tion by puncturing the tumor with a needle (output
power 30–70 w for 30 s), and dissociation was car-
ried out for 30 s to dissociate an electrode from
coagulated tissue. This cycle was repeated approx-
imately 10 times in the present case by changing
the position of the electrode. Bleeding from a tu-
mor by puncture with a needle immediately
stopped after microwave irradiation. Then necrotic
tissue was reduced by using forceps. Further nee-
dle-puncturing was performed under direct vision.
Care was taken to prevent complications to the
eye and other important surrounding tissue.Figure 3 Strong FDG uptake is seen in the left maxillary
sinus (arrowhead).Case report
A 78-year-old woman was referred to the
Department of Dentistry and Oral Surgery, Univer-
sity of Fukui Hospital, complaining of an ill-fitting
denture with swelling and pain in the left maxillary
alveolar region. Clinical examination revealed a
2528 mm lesion in the left maxillary alveolus
(Fig. 2(A)). [18F]-fluorodeoxyglucose positron emis-Figure 1 (A) Illustration of the microwave coagulator
‘‘Microtaze’’. (B) Illustration of some kinds of single
(left) and double (right) needle electrodes.sion tomography (FDG-PET) demonstrated strong
FDG uptake in the left maxillary sinus (Fig. 3). Mag-
netic resonance imaging (MRI) demonstrated an
expansive left maxillary sinus mass with bone
destruction and invasion to contiguous structures
including the nasal cavity, temporal fossa, and pal-
ate (Fig. 4(A) and (B)). A biopsy specimen derived
from the oral lesion was composed of neoplastic
growth of atypical clear cells and a monomorphousFigure 4 Axial (A) and coronal (B) MRI show locally
advanced mass in the left maxillary sinus. Axial (C) and
coronal (D) MRI do not show any tumor growth.
Figure 5 (A) Tumor tissue derived from oral lesion in
the first operation shows neoplastic growth of atypical
clear cells that form small nests (HE · 200). (B) Tumor
tissue derived from oral lesion in the second operation
shows coagulation-induced necrotic area and viable
tumor cells in a fibrous stroma (HE · 100).
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optically clear cytoplasm. These cells had round
nuclei and formed small nests. These characteris-
tics are consistent with clear cell adenocarcinoma
(T4N0MX, stage IV; Fig. 5(A)). The origin of this car-
cinoma was probably the gland of the maxillary
sinus.
First, we planned combined therapy with preop-
erative chemoradiotherapy and radical surgery for
clear cell adenocarcinoma of the maxillary sinus.
Although radiation therapy was delivered at a dose
of 60 grays (Gy) and regional intraarterial infusion
chemotherapy was performed using 23.6 mg of
pirarubicin hydrochloride (THP), 250 mg of 5-fluo-
rouracil (5-FU), and 350 mg of carboplatin (CBDCA)
for maxillary sinus tumor, these therapies were less
effective and tumor protrusion into the oral cavity
was still observed. A general detailed examination
was simultaneously carried out. Computed tomog-
raphy (CT) and a blood test revealed hepatocellular
carcinoma and lung metastasis, which were diag-
nosed as inoperable. Whether maxillary sinus carci-
noma was metastasis of hepatocellular carcinoma,
and the origin of the lung’s metastasis were not
confirmed because the patient refused further de-
tailed examinations. However, most malignant tu-
mors of the maxillofacial region are primary;
metastatic cases account for only 1% of all malig-
nant oral lesions.6 Moreover, hepatocellular carci-
noma metastatic to the maxillary sinus is very
unusual.7 Therefore, the treatment plan changed
from radical treatment to palliative treatment.
Transcatheter arterial embolization was performed
for hepatocellular carcinoma, then the patient
underwent MCT for tumor volume reduction of
maxillary sinus clear cell adenocarcinoma by intra-
oral approach. The first time, MCT was performed
under local anesthesia, and the patient complained
of severe pain. Therefore, the second time, MCT
was performed under general anesthesia per thepatient’s request. Effective tumor reduction was
achieved with only slight bleeding (Fig. 2(B)), and
the presence of necrotic tissue was confirmed by
histological examination (Fig. 5(B)). Importantly,
good local control was obtained without side ef-
fects such severe pain and bleeding after the sec-
ond MCT. Further, forty-five days after the
second MCT, no obvious tumor growth could be rec-
ognized (compare Fig. 4(A) and (B) with Fig. 4(C)
and (D)).
Approximately six months after the second MCT,
development of an intraoral mass was observed.
However, we did not perform MCT because of the
patient’s poor general condition, including severe
liver dysfunction and multiple lung- and osteo-
metastases. The patient died of these diseases four
months later.Discussion
Maxillary sinus carcinomas are usually locally ad-
vanced and invade the surrounding structures by
the time of diagnosis because their symptoms are
nonspecific and resemble sinusitis.8 In general,
the majority of maxillary sinus carcinoma patients
undergo combined therapy with (conservative or
radical) surgery, radiotherapy9,10 and regional che-
motherapy.11,12 Additionally, preoperative chemo-
radiation has also been reported to have a certain
measure of efficacy for adenocarcinoma.13 The
present case, a combined therapy was selected
first. However, the treatment plan had to be chan-
ged to palliative treatment because chemoradio-
therapy resulted in minor response and because
the patient had inoperable multiple cancers.
MCT is a technique that achieves thermal necro-
sis through the conversion of electrical energy to
heat. Microwaves, which have a great ability to
localize the deposition of energy, cause water mol-
ecules to become polarized within the rapidly
alternating electromagnetic field. This, in turn,
leads to the heating of intracellular water and con-
sequent coagulative necrosis. This therapy can
coagulate tissue from surface to profound part.
This therapy has a high ability to achieve hemosta-
sis compared with an external-heating method like
a laser or an electrosurgical scalpel. Moreover, it
can prevent the flow of cancer cells into the sur-
rounding blood vessels because it can seal vessels
up to 3 mm in diameter as a result of effective
coagulation.
One of the disadvantages of MCT is the difficulty
of controlling a coagulation area precisely, as
compared with cryosurgery and laser surgery.
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orbital region and skull base. Furthermore, we
cannot use it for a pacemaker user because that
device’s dissociative electric current is harmful.
In a case of advanced cancer, especially in inop-
erable cases, it is important to lay emphasis on lo-
cal control and pain control to preserve normal
function and appearance.14 MCT is reported to be
a useful therapy for local control of small liver tu-
mor. For palliative tumor local control, MCT was
useful and superior to other treatments from the
viewpoint of this patient’s quality of life. In fact,
our patient did not complain of severe pain and
we did not recognize any notable bleeding after
MCT. Moreover, MRI showed the necrotic change
of a central part of the left maxillary sinus tumor,
which was verified from the histopathological fea-
tures (Figs. 4 and 5). In this case, a third MCT
was not performed in consideration of the patient’s
poor general condition. However, MCT can be used
several times for advanced tumors, because MCT
itself is a simple and low-risk procedure. Practical
clinical approaches using this MCT offer a new
direction that shows promise of significant progress
in maxillofacial region oncology.References
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